Business Description
Basilea Pharmaceutica is a Swiss biotechnology company founded in 2000 and based near Basel, Switzerland, that develops and sells medicines to treat serious bacterial and fungal infections. Its two approved products, Cresemba and Zevtera, address life-threatening conditions such as invasive mold infections, dangerous staph bloodstream infections, and pneumonia. The company is also advancing a pipeline of new treatments at various stages of research, including novel antifungals and antibiotics targeting drug-resistant infections. To support its discovery efforts, Basilea works with outside partners, including a venture that uses artificial intelligence to accelerate antibiotic development.
